Compare
Yupelri vs. Atrovent HFA

Yupelri (revefenacin) is an inhalation solution that's used to treat adults with chronic obstructive pulmonary disease (COPD). It belongs to the drug class called long-acting muscarinic antagonists, or LAMAs. Yupelri (revefenacin) is inhaled through the mouth once a day using a nebulizer machine. Some possible side effects include headache and cough. Yupelri (revefenacin) is a brand-name medication; there's currently no generic version available.

• Chronic obstructive pulmonary disease (COPD)

• Cough (4%)
• Symptoms of a common cold (4%)
• Upper respiratory tract infection (4%)
• Headache (4%)
• Back pain (2%)

• Sudden trouble breathing
• Eye problems
• Problems with urination
• Allergic reactions

Atrovent HFA (ipratropium) is a short-acting inhaled anticholinergic medication used to help with difficulty breathing in people with chronic obstructive pulmonary disease (COPD). This medication comes in an inhaler. Typically, you breathe in 2 inhalations, 4 times a day. You should use Atrovent HFA (ipratropium) regularly every day in order it for it to keep your COPD symptoms under control. It's not meant to be used as a rescue inhaler.

• Maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults

• Cough and other symptoms of bronchitis (10-23%)
• Worsened COPD symptoms (8-23%)
• Trouble breathing (7-8%)
• Tiredness, chills, and other flu-like symptoms (4-8%)
• Headache (6-7%)
• Back pain (2-7%)

• Severe allergic reactions
• Narrowing of your airways (bronchospasm)
• Risk of eye and vision problems
• Trouble urinating